KB Home unveils its first 'fire-resilient' community in Southern California
Just months after raging wildfires destroyed thousands of homes in the Los Angeles area, California-based KB Home is unveiling what it calls its first 'wildfire-resilient' community.
The development, in Escondido, just outside San Diego, will have 64 single-family homes when completed that all meet the wildfire resilience standards developed by the Insurance Institute for Business & Home Safety (IBHS), a nonprofit, scientific research and communications organization supported by property insurers. These standards are designed to protect the homes against the three major sources of ignition during a wildfire: Flying embers, flames and radiant heat.
A handful of homes in the development are now complete, with roughly 20 homes already sold. Three homeowners have moved in, according to KB Home.
The homes are built with covered gutters, enclosed eaves, noncombustible siding — like stucco and fiber cement — tempered-glass windows, and non-combustible patios, doors and roofing. They have six-inch vertical clearance using the concrete foundation, stucco and stone. They also incorporate defensible space with low-combustible vegetation at least 5 feet from the homes. Metal fencing is used throughout the neighborhood.
Steve Ruffner, regional general manager of KB Home's coastal division, said he and his colleagues saw a fire-resistant home demonstration by IBHS at the Pacific Coast Builders Conference last summer and were impressed by the opportunity this type of community presented. Since KB Home had already broken ground on the development, they had to change gears quickly to incorporate the fire-resilient components.
'We had to change the architecture on the fly to a more stucco-oriented architecture with fire-resistant shutters, or fire-free shutters and doors and tempered windows. We were able to do that really quickly with the city, because they wanted to work with us. They really understood that this was important for their city,' Ruffner said.
He called it more of a research and development project to see what the costs might be and how to work with trade partners to lower that cost, although he wouldn't say how much those costs increased.
The homes range from $1 million to the low millions, which tends to be a move-up price in that area for single-family, detached homes.
'We're trying to get the cost to a reasonable place, because we really specialize in first-time buyers and first-time move-up buyers. So we want to make sure we can get this in a good place where it's affordable to do it and it's also got a good payback to the customer in a form of safety,' he added.
As climate change causes more severe drought in more areas of the country, focus is shifting to fire-resistant homes and communities.
During the the Palisades Fire in January, some homes that had been specifically built to fire-resistant standards remained unscathed while everything around them was destroyed. These types of homes, however, are largely one-offs by custom builders.
There has been progress in California on a home-by-home basis, according to IBHS, but KB Home is the first big production builder in the country that has designed and is fully building out 64 homes all to meet the wildfire-prepared neighborhood standard.
Among the specifications, homes are spaced 10 feet apart to help slow the progression of a fire.
'This subdivision built by KB Home, it's really the test bed to show this and demonstrate it,' said Roy Wright, CEO of IBHS. 'I know that KB Home already has two other projects here in Escondido, looking at duplexes and other kinds of town homes, and I do imagine that other builders are going to quickly follow suit. They're going to be building the homes that Californians want to buy.'
Wright emphasized that part of the draw is not just to build a home that is survivable, but also one that is insurable. Insurance companies have been pulling out of California in droves, leaving homeowners with soaring costs and some without insurance entirely.
Though the homes are billed as fire-resilient, that doesn't mean they are entirely risk-free. Homeowners and cities are going to have to make changes when it comes to non-combustible landscaping, elevations and even design. The real test will come in the future, should the community be in the line of a wildfire.
'Nothing is ever fireproof. We're always just seeking to try to narrow those paths of destruction,' said Wright.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
30 minutes ago
- Reuters
Delta warns new tariffs could force it to stop buying foreign-made airplanes
WASHINGTON, June 5 (Reuters) - Delta Air Lines (DAL.N), opens new tab warned new tariffs on imported airplanes and parts could force the airline to stop buying foreign-made planes impacting millions of customers. The Atlanta-based carrier told the U.S. Commerce Department in comments seen by Reuters Thursday that in 2023 and 2024 it took delivery of 47 Airbus ( opens new tab aircraft produced in Canada, Germany and France. If the carrier had not been able to take delivery of those planes because of tariffs it would have forced flight cancellations impacting 10 million customers. Delta said a "similar impact could be expected going forward" if the Trump administration imposes new tariffs.
Reuters
an hour ago
- Reuters
Anduril secures $30.5 billion valuation in latest fund raise
June 5 (Reuters) - Defense technology startup Anduril Industries has clinched a valuation of $30.5 billion in its latest funding round where it raised $2.5 billion, the company said on Thursday. This round more than doubled the Palmer Luckey-founded company's valuation, from $14 billion last year when it raised $1.5 billion. The development confirms a Reuters report from February, which said Anduril was in talks to raise as much as $2.5 billion, with tech billionaire Peter Thiel's Founders Fund set to lead the round. Anduril said on Thursday that Founders Fund made a $1 billion investment, while all other investors raised their commitments from previous rounds in the Series G fund raise. Founders Fund has backed Anduril since its inception in 2017, and one of the company's co-founders, Trae Stephens, is a partner at the firm. Anduril develops solutions, including a wide range of sensors and drones, and has gained prominence in the industry amid increasing calls for low-cost autonomous defense products. The company has also recently secured a partnership with Palantir Technologies to form a consortium that will look to jointly bid for government contracts as the Pentagon aims to reduce costs.
Reuters
an hour ago
- Reuters
Four Democratic-led US states urge FDA to remove abortion pill restrictions
NEW YORK, June 5 (Reuters) - The attorneys general of New York, California, Massachusetts and New Jersey asked the Food and Drug Administration to expand access to the abortion pill mifepristone, and remove what they view as outdated and medically unnecessary restrictions. Thursday's petition by the Democratic-led states seeks to force the FDA to acknowledge what the states view as "extensive" evidence that mifepristone is safe, notwithstanding the Trump administration's general opposition to abortion. It came after Health and Human Services Secretary Robert F. Kennedy Jr told Congress last month he ordered FDA Commissioner Marty Makary to review the pill, and unspecified "alarming" new data suggested the government should at least change the label. Mifepristone is the first pill, followed by the drug misoprostol, for medication abortion in the first 10 weeks of pregnancy, and won FDA approval in 2000. Medication abortions account for more than half of U.S. abortions, though 28 states restrict access, according to the nonprofit Guttmacher Institute, which focuses on reproductive health. The petition challenges FDA requirements that mifepristone prescribers be included in national and local abortion provider lists, patients attest in writing that they intend to end their pregnancies, and pharmacies perform a variety of recordkeeping. Citing the drug's safety record, it said those rules, part of the FDA's Risk Evaluation and Mitigation Strategy program, are "no longer justified by science or law," especially in states where abortion is legal and comprehensively regulated. New York Attorney General Letitia James said the rules keep mifepristone out of reach of most primary care settings. She called that problem particularly acute in rural and other areas where getting abortions often requires lengthy travel. "There is simply no scientific or medical reason to subject it to such extraordinary restrictions," James said, referring to mifepristone. "The FDA must follow the science." A spokeswoman for the Department of Health and Human Services said FDA Commissioner Makary "will ensure gold standard science is used while incorporating practical, common-sense considerations to its regulatory processes." Many states, primarily Republican-led or leaning, have restricted or substantially eliminated abortions in the three years since the U.S. Supreme Court overturned Roe v. Wade, the 1973 decision that legalized the procedure nationwide. Last June, the Supreme Court preserved broad access to mifepristone, unanimously ruling that a group of anti-abortion organizations and doctors lacked legal standing to challenge the FDA's approval of the pill. Despite largely siding with abortion opponents, Republican President Donald Trump said during his 2024 campaign he did not plan to limit access to mifepristone. Last month, the administration asked a federal judge to dismiss, on procedural grounds, a lawsuit by three generally Republican states seeking to narrow such access. That lawsuit began during the administration of Democratic President Joe Biden, who generally supported abortion access. Seventeen other Democratic-led or -leaning states plus Washington, D.C., are separately suing the FDA in Spokane, Washington, to loosen restrictions on mifepristone. They said doctors and pharmacies should be able to dispense the pill, as with most drugs, without special certifications. On May 30, the Trump administration urged a dismissal, saying the states didn't show the FDA's policy was flawed or the agency ignored important evidence. The states filed Thursday's petition after a short delay, with the filing having been expected earlier in the morning.
